Elevated Perioperative Serum Vascular Endothelial Growth Factor Levels in Patients with Colon Carcinoma

Cancer

Volumn 100, Issue 2, 2004, Pages 270-278

  De Vita, Ferdinando ^a,b   Orditura, Michele ^a   Lieto, Eva ^a   Infusino, Stefania ^a   Morgillo, Floriana ^a   Martinelli, Erika ^a   Castellano, Paolo ^a   Romano, Ciro ^a   Ciardiello, Fortunato ^a   Catalano, Giuseppe ^a   Pignatelli, Carlo ^a   Galizia, Gennaro ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b FEDERICO II UNIVERSITY HOSPITAL   (Italy)

Author keywords

Colon carcinoma; Prognosis; Surgery; Vascular endothelial growth factor serum levels

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GRADING; CANCER SURVIVAL; COLON CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SEX DIFFERENCE; TUMOR LOCALIZATION; TUMOR VOLUME;

CARCINOMA; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 9144269918     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11911     Document Type: Article

References (21)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 1990;82:4-6.
2. Papetti M, Herman IM. Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol. 2002;282:947-970.
3. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocrine Rev. 1997;18:4-25.
4. Torimura T, Sata M, Ueno T, et al. Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma. Hum Pathol. 1998;29:986-991.
5. Sanger DR, Claffey KP, Benes JE, Perruzzi CA, Sergiou AP, Detmar M. Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc Natl Acad Sci USA. 1997;94:13612-13617.
6. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol. 1995;146:1029-1039.
7. Robinson CJ, Stringer SE. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci. 2001;114:853-865.
8. Neufeld G, Cohen T, Gengrinovitch P, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999;13:9-22.
9. Senger DR, Perruzzi CA, Feder J, Dvorak HF. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res. 1986;46:5629-5632.
10. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med. 1999;77:527-543.
11. TakahashiY, Kitadai Y, Bucana CD, Cleary KR, Ellis LM. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer. Cancer Res. 1995;55:3964-3968.
12. Ellis LM, Takahashi Y, Liu W, Shaheen RM. Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications. Oncologist. 2000;5:11-15.
13. Nakayama Y, Sako T, Shibao K, et al. Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancer. Anticancer Res. 2002;22:2437-2442.
14. Tokunaga T, Oshika Y, Abe Y, et al. Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor performance prognosis in colon cancer. Br J Cancer. 1998;77:998-1002.
15. Ishigami SI, Arii S, Furutani M, et al. Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br J Cancer. 1998;78:1379-1384.
16. Takahashi Y, Tucker SL, Kitadai Y, et al. Vessel count and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg. 1997;132:541-546.
17. Cascinu S, Staccioli MP, Gasparini G, et al. Expression of vascular endothelial growth factor can predict event-free survival in Stage II colon cancer. Clin Cancer Res. 2000;6:2803-2807.
18. Werther K, Christensen IJ, Brunner N, Nielsen HJ, and Danish RANX05 Colorectal Cancer Study Group. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. Eur J Surg Oncol. 2000;26:657-662.
19. Werther K, Christensen IJ, Nielsen HJ, and Danish RANX05 Colorectal Cancer Study Group. The association between preoperative concentration of soluble vascular endothelial growth factor perioperative blood transfusion and survival in patients with primary colorectal cancer. Eur J Surg. 2001;167:287-292.
20. Werther K, Christensen IJ, Nielsen HJ, and Danish RANX05 Colorectal Cancer Study Group. Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma. Br J Cancer. 2002;86:417-423.
21. Poon RT, Lau CP, Cheung ST, Yu WC, Fan ST. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma. Cancer Res. 2003;63:3121-3126.